Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 30, 1995

Primary Completion Date

May 31, 2002

Conditions
Head and Neck Cancer
Interventions
DRUG

paclitaxel

Trial Locations (29)

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

14642

University of Rochester Cancer Center, Rochester

15213

University of Pittsburgh Cancer Institute, Pittsburgh

19111

Fox Chase Cancer Center, Philadelphia

21287

Johns Hopkins Oncology Center, Baltimore

30033

Veterans Affairs Medical Center - Atlanta (Decatur), Decatur

30322

Emory University Hospital - Atlanta, Atlanta

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

37212

Veterans Affairs Medical Center - Nashville, Nashville

48106

CCOP - Ann Arbor Regional, Ann Arbor

53705

Veterans Affairs Medical Center - Madison, Madison

53792

University of Wisconsin Comprehensive Cancer Center, Madison

55416

CCOP - Metro-Minnesota, Saint Louis Park

55455

University of Minnesota Cancer Center, Minneapolis

55805

CCOP - Duluth, Duluth

60611

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

Veterans Affairs Medical Center - Chicago (Lakeside), Chicago

61801

CCOP - Carle Cancer Center, Urbana

68131

CCOP - Missouri Valley Cancer Consortium, Omaha

94304

Veterans Affairs Medical Center - Palo Alto, Palo Alto

94305-5408

Stanford University Medical Center, Stanford

52403-1206

CCOP - Cedar Rapids Oncology Project, Cedar Rapids

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

07018-1095

Veterans Affairs Medical Center - East Orange, East Orange

07601

CCOP - Northern New Jersey, Hackensack

44106-5065

Ireland Cancer Center, Cleveland

19102-1192

Hahnemann University Hospital, Philadelphia

37232-6838

Vanderbilt Cancer Center, Nashville

0001

Pretoria Academic Hospital, Pretoria

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00002632 - Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer | Biotech Hunter | Biotech Hunter